Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06336720 · ClinicalTrials.gov registry record · NA
PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study
A NA study of Chronic Stroke Survivors, sponsored by Helius Medical.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 5
- Study locations
NCT06336720: Active NA study of Chronic Stroke Survivors, sponsored by Helius Medical.
NCT06336720 is a NA study of Chronic Stroke Survivors that is active but no longer recruiting, run by Helius Medical. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06336720, a NA study of Chronic Stroke Survivors, is active but no longer recruiting, sponsored by Helius Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 5
- Study locations
Study Summary
Primary Objective: To further evaluate the aspects of safety related to PoNS therapy in chronic stroke survivors. Secondary Objectives: To further evaluate the efficacy of PoNS on improving dynamic gait and balance, establishing durability of effect, risk of falling and fall rate. As well as adherence to PoNS device utilization. Exploratory Objectives: To further evaluate quality of life to measure physical, mental, behavioral, and general health, as well as functional decline (\> 30% on gait or balance improvement at endpoint) during the 12-week follow-up.
Primary Outcome
treatment - related serious adverse events (SAE) over 12 week treatment
Conditions Studied
Interventions
- DEVICE Portable Neuromodulation Stimulator (PoNS)
Study Locations (5)
Massachusetts
- MGH Institute of Health Professions - Boston
- Neurology Center of New England, P.C. - Foxborough
Florida
- Brooks Rehabilitation - Jacksonville
Georgia
- Shepherd Center - Atlanta
New York
- Rehabologym Corp - Tarrytown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What the registry record for NCT06336720 still lists
NCT06336720 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Chronic Stroke Survivors appearing as the primary indexed condition, and to 1 intervention - of which Portable Neuromodulation Stimulator (PoNS) is the first listed.
NCT06336720 lists 5 locations in 4 states (Massachusetts, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT06336720 about?
NCT06336720 is a clinical study titled "PoNS® Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study". Primary Objective: To further evaluate the aspects of safety related to PoNS therapy in chronic stroke survivors. Secondary Objectives: To further evaluate the efficacy of PoNS on improving dynamic gait and balance, establishing durability of effect, risk of falling and fall rate. As well as adhere...
What is the current status of trial NCT06336720?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-01. Estimated completion is 2026-09-30.
What conditions does trial NCT06336720 study?
This clinical trial studies the following conditions: Chronic Stroke Survivors.
What interventions are being tested in trial NCT06336720?
The interventions under investigation include: Portable Neuromodulation Stimulator (PoNS) (DEVICE).
Who is sponsoring clinical trial NCT06336720?
This trial is sponsored by Helius Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06336720 being conducted?
This trial has 5 study locations across Florida, Georgia, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Stroke Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06336720's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI